tiprankstipranks
Immunovant (IMVT)
NASDAQ:IMVT

Immunovant (IMVT) Cash flow

701 Followers

Immunovant Cash Flow

IMVT's free cash flow for Q2 2024 was $-60.09M. For the 2024 fiscal year, IMVT's free cash flow was decreased by $-82.02M and operating cash flow was $-60.06M. See a summary of the company’s cash flow.
Cash Flow
TTM
Mar 23Mar 22Mar 21Mar 20Dec 18
Operating Cash Flow
$ -209.62M$ -188.19M$ -106.11M$ -83.33M$ -53.36M$ 0.00
Investing Cash Flow
$ -203.00K$ -197.00K$ -254.00K$ -210.00K$ -31.00K-
Financing Cash Flow
$ 71.90M$ 70.89M$ 129.00K$ 383.11M$ 146.97M$ 325.00K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 1.41B$ 376.53M$ 293.82M$ 400.15M$ 100.57M$ 325.00K
Income Tax Paid Supplemental Data
---$ 166.00K$ 61.00K-
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
---$ 319.78M$ 0.00$ 25.00K
Issuance Of Debt
---$ 0.00$ 42.91M$ 300.00K
Repayment Of Debt
---$ -3.19M$ -5.00M-
Free Cash Flow
$ -209.82M$ -188.39M$ -106.37M$ -83.54M$ -53.39M$ 0.00
Domestic Sales
------
Foreign Sales
------
Currency in USD

Immunovant Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis